Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
The British Journal of Dermatology
|
August 25, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
A L Bosma, P I Spuls, I Garcia-Doval, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 20, 2025
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce
A H Musters, L A A Gerbens, L van der Gang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 31, 2020
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis
A Wollenberg, C Flohr, D Simon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 18, 2022
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy
A Wollenberg, M Kinberger, B Arents, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 15, 2021
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
J P Thyssen, C Vestergaard, S Barbarot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 24, 2022
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)
J Zitouni, A-C Bursztejn, A Belloni Fortina, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 22, 2021
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts
J Ring, M Worm, A Wollenberg, et al.
The British Journal of Dermatology
|
October 17, 2015
Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey
E Wedgeworth, M Glover, A D Irvine, et al.
The British Journal of Dermatology
|
April 20, 2018
Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
J R Chalmers, K S Thomas, C Apfelbacher, et al.
The British Journal of Dermatology
|
July 21, 2016
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
J R Chalmers, E Simpson, C J Apfelbacher, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
The British Journal of Dermatology
|
August 25, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
A L Bosma, P I Spuls, I Garcia-Doval, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 20, 2025
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce
A H Musters, L A A Gerbens, L van der Gang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 31, 2020
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis
A Wollenberg, C Flohr, D Simon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 18, 2022
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy
A Wollenberg, M Kinberger, B Arents, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 15, 2021
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
J P Thyssen, C Vestergaard, S Barbarot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 24, 2022
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)
J Zitouni, A-C Bursztejn, A Belloni Fortina, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 22, 2021
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts
J Ring, M Worm, A Wollenberg, et al.
The British Journal of Dermatology
|
October 17, 2015
Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey
E Wedgeworth, M Glover, A D Irvine, et al.
The British Journal of Dermatology
|
April 20, 2018
Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
J R Chalmers, K S Thomas, C Apfelbacher, et al.
The British Journal of Dermatology
|
July 21, 2016
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
J R Chalmers, E Simpson, C J Apfelbacher, et al.
Page
of 10